Resuscitating a Culture One Beat at a Time
Executive Summary
Its acquisition of privately held Zymed means more to the Healthcare Solutions Group (HSG) of Agilent Technologies than being able to fill a gap in its cardiology business. It is also a part of Agilent's drive to energize its corporate culture following its spin-out of Hewlett-Packard last year. Moreover, in the face of disappointing earnings from HSG and poor near-term growth prospects, Agilent's overall commitment to health care was questioned by Wall Street.You may also be interested in...
Compliance Corner: The 10 Best – And 10 Worst – Things You Can Do When FDA Inspects Your Firm (Part 4)
A panel of longtime industry experts offer manufacturers a list of things they should and shouldn’t do when an investigator from the US agency knocks on their facility door. In this fourth installment of a 10-part series, the experts address so-called back rooms used by manufacturers during an inspection.
Industry Needs To Engage On Antimicrobials
Recruiting generics firms to the AMR Industry Alliance is a key area of focus for the group as part of its efforts to cover a greater proportion of the global supply of antimicrobials, according to the Alliance’s latest report.
December ANDA Rush Is Largest In Two Years
December's ANDA rush has provided the largest monthly haul in two years. However, the month may be losing its influence over the US FDA's annual submission total.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports